Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
AstraZeneca
QuintilesIMS
Dow
Queensland Health
Mallinckrodt
Moodys
Fuji
Johnson and Johnson
Colorcon

Generated: August 20, 2017

DrugPatentWatch Database Preview

PLEGINE Drug Profile

« Back to Dashboard

Which patents cover Plegine, and when can generic versions of Plegine launch?

Plegine is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in PLEGINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for Tradename: PLEGINE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list8
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PLEGINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
PLEGINE
phendimetrazine tartrate
TABLET;ORAL012248-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Colorcon
Queensland Health
Express Scripts
Deloitte
Citi
Moodys
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot